Better Artificial Intelligence Stock: Palantir vs. UiPath

Palantir (PLTR) has significantly outpaced UiPath (PATH) in stock performance and fundamental growth, with its revenue CAGR of 27% (2020-2024) and GAAP profitability since 2023, compared to UiPath's 24% revenue CAGR (2021-2025) and projected GAAP profitability in fiscal 2026. While Palantir, a data aggregation specialist, is forecast for 41% revenue growth, UiPath, a robotic process automation leader facing generative AI competition, anticipates 9% growth. However, Palantir's current valuation at 83 times next year's sales is considered extremely high, leading to a preference for UiPath's more reasonable 5 times next year's sales, despite its slower growth and competitive headwinds.

Analysis

Palantir (PLTR) has significantly outperformed UiPath (PATH) in stock performance, soaring over 340% compared to PATH's 13% rise since last October, reflecting its stronger fundamental growth and earlier GAAP profitability. PLTR achieved a 27% revenue CAGR from 2020-2024, reaching $2.9 billion, and became GAAP profitable in 2023, while PATH's revenue grew at a 24% CAGR from 2021-2025, reaching $1.4 billion, with GAAP profitability projected for fiscal 2026. This divergence highlights PLTR's current market leadership in data aggregation.

Palantir's growth re-accelerated in 2024-2025, driven by increased government spending due to military conflicts and a stabilizing macro environment, with analysts forecasting a 41% revenue CAGR and 37% GAAP EPS CAGR through 2027. Conversely, UiPath experienced significant top-line deceleration, with only 9% revenue growth in fiscal 2025, primarily due to macro headwinds and intense competition from generative AI tools. This competitive pressure poses a structural challenge to UiPath's core RPA offerings, despite its cost-cutting efforts.

Despite Palantir's superior growth and operational strength, its valuation at 83 times next year's sales is deemed extremely high, presenting a significant risk of a steep pullback and limiting future upside. In contrast, UiPath, trading at a more reasonable five times next year's sales, offers a comparatively attractive valuation despite its slower growth trajectory and competitive pressures. The article's cautious tone and negative sentiment towards PLTR underscore concerns about its current market pricing.

Key Decisions for Investors

• Investors should exercise caution with Palantir (PLTR) due to its extremely high valuation of 83 times next year's sales, which suggests limited upside potential and increased risk of a significant correction despite its strong growth prospects.
• Consider UiPath (PATH) for a more reasonably valued entry into the AI automation space, as its current valuation of five times next year's sales offers a better risk-reward profile despite facing competitive headwinds from generative AI and slower revenue growth.
• Monitor UiPath's ability to integrate new AI capabilities and manage competition from generative AI tools, as well as Palantir's ability to sustain its premium valuation amidst potential market volatility.